Mumbai,: Marengo Asia Hospitals is aiming for a ₹5,000 crore valuation as it plans to raise ₹500 crore through a strategic stake sale, marking a significant step in its growth and expansion strategy within India’s healthcare sector.

The proposed fundraise is expected to attract strategic and financial investors, with the company looking to strengthen its capital base to support network expansion, infrastructure upgrades, and technology integration across its hospitals. The move comes amid increasing investor interest in India’s rapidly growing healthcare market.

According to industry sources, the capital infusion will be utilized to scale operations, enhance clinical capabilities, and expand into new geographies, aligning with the company’s long-term vision of building a robust multi-specialty healthcare network.

Marengo Asia Hospitals has been actively expanding its footprint, focusing on delivering high-quality, patient-centric care supported by advanced medical technologies. The planned stake sale is expected to provide the necessary financial backing to accelerate this growth trajectory.

Experts note that healthcare continues to be a high-growth sector in India, driven by rising demand, increasing health awareness, and greater private sector participation. Investments in hospital chains are gaining momentum as providers look to scale capacity and improve service delivery.

The valuation target of ₹5,000 crore reflects confidence in Marengo’s business model, operational performance, and future growth potential, as well as broader market optimism around healthcare investments.

With this move, Marengo Asia Hospitals aims to strengthen its position in the competitive healthcare landscape while continuing to expand access to quality medical services across the country.